BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15812888)

  • 21. [Using ANN and serum protein pattern models in liver cancer diagnosis].
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):189-92. PubMed ID: 15854466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of serum protein pattern model in diagnosis of colorectal cancer].
    Chen YD; Zheng S; Yu JK; Hu X
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):417-20. PubMed ID: 15355647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying biomarkers of endometriosis using serum protein fingerprinting and artificial neural networks.
    Wang L; Zheng W; Mu L; Zhang SZ
    Int J Gynaecol Obstet; 2008 Jun; 101(3):253-8. PubMed ID: 18325521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of distinct protein profiles for early diagnosis of NSCLC using LCM and SELDI-TOF-MS.
    Yang S; Nan Y; Tian Y; Zhang W; Zhou B; Bu L; Huo S; Chen G; Yu J; Zheng S
    Med Oncol; 2008; 25(4):380-6. PubMed ID: 18300004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of pancreatic cancer with normal carbohydrate antigen 19-9 using protein chip technology.
    Jin XL; Xu B; Wu YL
    World J Gastroenterol; 2014 Oct; 20(40):14958-64. PubMed ID: 25356057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analyzing urinary proteome patterns of metabolic syndrome patients with early renal injury by magnet bead separation and matrix-assisted laser desorption ionization time-of-flight mass spectrometry].
    Gao BX; Li MX; Liu XJ; Cai JF; Fan XH; Yang XL; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):511-6. PubMed ID: 22338134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of serum protein fingerprint in diagnosis of coronary artery disease.
    Wang Y; Hu X; Wang JA; Xiang M; Yu J; Liu F; Feng Y
    Clin Biochem; 2011 Feb; 44(2-3):185-91. PubMed ID: 20950597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
    Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of renal allograft subclinical rejection by urine protein fingerprint analysis.
    Mao Y; Yu J; Chen J; Yang H; He Q; Shou Z; Wu J; Zheng S
    Transpl Immunol; 2008 Jan; 18(3):255-9. PubMed ID: 18047934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
    Shen F; Zhang Y; Yao Y; Hua W; Zhang HS; Wu JS; Zhong P; Zhou LF
    Neurosurg Rev; 2014 Jul; 37(3):367-80; discussion 380. PubMed ID: 24781189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Proteomic analysis in combination with CT diagnosis to distinguish renal cell carcinoma from renal benign masses].
    Xu G; Xiang CQ; Lu Y; Kang XN; Wang WJ; Liao P; Ding Q; Zhang YF
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):858-60. PubMed ID: 18756995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry.
    Schwartz SA; Weil RJ; Thompson RC; Shyr Y; Moore JH; Toms SA; Johnson MD; Caprioli RM
    Cancer Res; 2005 Sep; 65(17):7674-81. PubMed ID: 16140934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum protein profiling of smear-positive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry.
    Liu Q; Chen X; Hu C; Zhang R; Yue J; Wu G; Li X; Wu Y; Wen F
    Lung; 2010; 188(1):15-23. PubMed ID: 20012079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of SELDI-TOF MS technology analyzing serum protein profiling for distinguishing laryngeal carcinoma from ordinary people].
    Zhang X; Chen Y; Wang J; Qu X; Deng B; Wang J; Xie G; Li M; Xu F
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Sep; 20(18):842-6. PubMed ID: 17144495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of serum proteomic mass spectrum analysis in breast cancer].
    Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.